{
  "paper_id": "e2b713ae83d29ae312546942e12c201b1e6f6a6b",
  "metadata": {
    "title": "New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL pro inhibitors",
    "coda_data_split": "train",
    "coda_paper_id": 5692,
    "coda_has_expert_labels": false,
    "subset": "custom_license"
  },
  "abstract": [
    {
      "original_text": "A series of trifluoromethyl, benzothiazolyl or thiazolyl ketone-containing peptidic compounds as SARS-CoV 3CL protease inhibitors were developed and their potency was evaluated by in vitro protease inhibitory assays. Three candidates had encouraging results for the development of new anti-SARS compounds.",
      "sentences": [
        [
          {
            "segment_text": "A series of trifluoromethyl , benzothiazolyl or thiazolyl ketone-containing peptidic compounds as SARS-CoV 3CL protease inhibitors were developed and their potency was evaluated by in vitro protease inhibitory assays .",
            "crowd_label": "method"
          }
        ],
        [
          {
            "segment_text": "Three candidates had encouraging results for the development of new anti-SARS compounds .",
            "crowd_label": "finding"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "1",
    "sentence_num": "2",
    "segment_num": "2",
    "token_num": "43"
  }
}